Sandra Cauwenberghs

Investor Relations Contact at GALAPAGOS NV

Health Technology

Consumer Services

Finance

Profile

Sandra Cauwenberghs is currently working as a Senior Director-Investor Relations at Galapagos NV.
Previously, she worked as an Analyst at KBC Securities NV from 2017 to 2020.
She also held the position of Head-Pharmacology at iTeos Therapeutics SA. Dr. Cauwenberghs holds a doctorate degree from Maastricht University and a graduate degree from Katholieke Universiteit Leuven.

Sandra Cauwenberghs active positions

Companies	Position	Start
GALAPAGOS NV	Investor Relations Contact	2020-10-31

All active positions of Sandra Cauwenberghs

Former positions of Sandra Cauwenberghs

Companies	Position	End
KBC Securities NV KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors.	Analyst-Equity	2020-10-31
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Corporate Officer/Principal	-

See the detail of Sandra Cauwenberghs's experience

Training of Sandra Cauwenberghs

Maastricht University	Doctorate Degree
Katholieke Universiteit Leuven	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sandra Cauwenberghs's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GALAPAGOS NV	Health Technology

Private companies	2
KBC Securities NV KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors.	Finance
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.	Health Technology